title: Cognitive enhancement: promises and perils.
abstract: The potential use of drugs to enhance cognition, emotion, and executive function has engendered controversy despite the fact that few such agents exist today. Here, I provide a context for discussions based on medical, regulatory, and ethical concerns that have been raised by the possibility that enhancers will emerge from current efforts to discover drugs for neuropsychiatric disorders.
authors.affiliation: Office of the Provost, Massachusetts Hall, Harvard University, Cambridge, MA 02138, USA. seh@harvard.edu
authors.forename: Steven E
authors.initials: SE
authors.lastname: Hyman
mesh_terms: D003071:Cognition / Q000187:drug effects* / Q000502:physiology; D003072:Cognition Disorders / Q000188:drug therapy; D006801:Humans; D018697:Nootropic Agents / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D018697:Nootropic Agents